# SUPERNUS PHARMACEUTICALS INC: Form D filings

SUPERNUS PHARMACEUTICALS INC, a pharmaceuticals company in Rockville, MD, filed 2 Form D notices with the SEC between 2011 and 2012. The latest, on February 16, 2012, reports $30 million sold of a $30 million offering to 3 investors.

Find out what SUPERNUS PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SUPERNUS%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SUPERNUS%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fsupernus-pharmaceuticals-inc-1356576)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SUPERNUS%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SUPERNUS%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fsupernus-pharmaceuticals-inc-1356576)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1550 E GUDE DR, Rockville, MD, 20850
- Phone: (301) 838-2500
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1356576

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 16, 2012 | Amendment | $30,000,000 | $30,000,000 | $0 | 3 | Jan 26, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1356576/000135657612000001/0001356576-12-000001-index.htm) |
| Feb 2, 2011 | New notice | $25,000,000 | $15,000,000 | $10,000,000 | 2 | Jan 26, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1356576/000135657611000002/0001356576-11-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| John M. Siebert | Director |  |
| Michael James Bigham | Director |  |
| William A. Nuerge | Director |  |
| Michael B. Sheffery, Ph.D. | Director |  |
| Padmanabh P. Bhatt, Ph.D. | Executive Officer |  |
| Charles W. Newhall, III | Director |  |
| M. James Barrett, Ph.D. | Director |  |
| Paolo P. Baroldi, M.D., Ph.D. | Executive Officer |  |
| Frederick M. Hudson | Director |  |
| Jack A. Khattar | Executive Officer, Director |  |
| Tami T. Martin, R.N., Esq. | Executive Officer |  |
| Russell P. Wilson | Executive Officer |  |
| Jones W. Bryan, Ph.D. | Executive Officer |  |

[Every Form D from the week of Feb 13, 2012](https://specstream.ai/data/form-d/week/2012-02-13) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what SUPERNUS PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).